Filter
570
Text search:
sequencing
Featured
Recommendations
67
New Publications
120
Language
Document type
No document type
240
Studies & Reports
107
Guidelines
92
Strategic & Response Plan
45
Manuals
40
Fact sheets
22
Situation Updates
11
Training Material
9
Resource Platforms
3
Infographics
1
Countries / Regions
India
20
Africa
19
Global
17
Western and Central Europe
13
Latin America and the Carribbean
12
Congo, Democratic Republic of
11
Liberia
9
Uganda
9
West and Central Africa
9
Russia
9
Nigeria
8
South Sudan
7
East and Southern Africa
7
Sierra Leone
6
Zimbabwe
6
Germany
6
Zambia
6
South Africa
6
Malawi
6
Ethiopia
5
Pakistan
5
Syria
5
Rwanda
5
Brazil
5
Ukraine
5
Eastern Europe
5
Cameroon
4
Ghana
4
Afghanistan
4
Kenya
4
Bangladesh
4
Myanmar / Burma
4
Middle East and North Africa
4
Côte d’Ivoire / Ivory Coast
3
Niger
3
Tanzania
3
Venezuela
3
Guinea
2
Mali
2
Haiti
2
Nepal
2
Chad
2
Cambodia
2
Mozambique
2
Sudan
2
Central African Republic
2
Peru
2
Angola
2
Eastern Europe and Central Asia
2
Asia
2
Laos
2
Burkina Faso
1
Senegal
1
Morocco
1
USA
1
Saudi Arabia
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
China
1
Mauritania
1
Papua New Guinea
1
Benin
1
Argentina
1
Dominican Republic
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Libya
1
Guatemala
1
Cape Verde
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Bhutan
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Denmark
1
France
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
149
Clinical Guidelines
69
Public Health
29
Key Resources
27
Pharmacy & Technologies
23
Women & Child Health
7
Capacity Building
5
Toolboxes
COVID-19
106
Rapid Response
55
TB
53
HIV
47
AMR
29
NTDs
28
Ebola
20
Polio
20
Planetary Health
19
Mental Health
18
Zika
15
Conflict
12
Caregiver
9
Natural Hazards
8
Refugee
6
Global Health Education
6
Disability
4
NCDs
4
Cholera
3
Pharmacy
3
Health Financing Toolbox
3
South Sudan
1
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
23 March 2021
The meeting addressed the last key area, that is, determining the best method or combination of diagnostic methods for a control programme for S. stercoralis infections in humans.
Dr Montresor’s presentation highlighted that while there is currently no “gold standard” for the
...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa
t contains action-oriented lists of critical topics to address and checklists tailored to the context of African Union Member States.
...
The COVID-19 Strategic Preparedness and Response Plan (SPRP) 2021 Monitoring and Evaluation Framework tracks global progress against the COVID-19 SPRP 2021 for the ten pillars of the public health response. The operational intelligence complements the epidemiologic information used to drive a global
...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T
...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukem
...
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an
...
Epidemic meningitis is a major public health challenge in the African 'meningitis belt', an area that extends from Senegal to Ethiopia with an estimated total population of 500 million. Since 2002, the World Health Organization (WHO), in collaboration with its collaborating centres for meningitis, h
...
This new plan has been developed to build on successes made and lessons learnt from implementation of the two initial plans and to provide a short to medium term strategic anchor against which preparedness and response plans to the corona virus disease COVID-19 epidemic in the country should focus o
...
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, published by the World Health Organization (WHO)
...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti
...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A
...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s
...
